2019 annual financial data
GT Biopharma 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,457,000 USD and net income was -38,647,000 USD.
Operating cash flow was -3,659,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,457,000 USD
- Net income
- -38,647,000 USD
- Operating cash flow
- -3,659,000 USD